Correction to: Oncogene advance online publication, 24 July 2017; doi: 10.1038/onc.2017.230
Following the publication of this article the authors noted errors in the labelling of Figures 1c and d. The figure legends should be exchanged so that Figure 1c reads ‘Representative image of immunohistochemical analysis for RCN2 expression in adjacent non-tumor tissues and tumor tissues of HCC patients.’, while Figure 1d should read ‘RCN2 level was examined by western blotting in paired HCC tissues. Relative signals are shown in the right panel.’
Second, in Supplementary Figure 2a, the connecting line in the right panel representing the comparison of cell growth between mock and restored QGY-7703 cell was not drawn correctly.
These errors have now been rectified. The html and online pdf versions have also been rectified, and now carry the corrected paper and Supplementary Figure.
The authors confirm that these errors have no impact on the conclusions of the paper and apologize for any inconvenience caused.
Additional information
The online version of the original article can be found at 10.1038/onc.2017.230
Rights and permissions
About this article
Cite this article
Ding, D., Huang, H., Jiang, W. et al. Erratum: Reticulocalbin-2 enhances hepatocellular carcinoma proliferation via modulating the EGFR-ERK pathway. Oncogene 36, 6747–6748 (2017). https://doi.org/10.1038/onc.2017.366
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2017.366